Tesshi Yamada
National Cancer Research Institute, Tokyo Medical University
Papers
2
Total Citations
40
H-Index
2
About
Dr. Tesshi Yamada is a leading surgical oncologist whose research focuses on improving outcomes for patients with gastrointestinal malignancies, particularly pancreatic and rectal cancers. A central theme of his work is the personalization of cancer therapy through biomarker discovery and the refinement of surgical techniques. In a seminal 2010 study, Dr. Yamada addressed the critical challenge of predicting survival in advanced pancreatic cancer patients receiving gemcitabine. By employing liquid chromatography-mass spectrometry (LC-MS), he identified novel serum biomarkers that could stratify patients, aiming to spare non-responders from ineffective treatment. This highly cited work (35 citations) laid groundwork for precision medicine in a notoriously difficult-to-treat disease. More recently, Dr. Yamada has been at the forefront of minimally invasive surgery. His 2024 study provides crucial long-term oncologic data comparing robot-assisted laparoscopic surgery (RALS) to conventional laparoscopic surgery (CLS) for rectal cancer. By demonstrating comparable or superior long-term outcomes, this research (5 citations) supports the adoption of advanced robotic platforms, offering patients the benefits of minimally invasive approaches without compromising cancer control. Dr. Yamada’s contributions bridge the gap between molecular prediction and surgical innovation, directly impacting clinical decision-making and patient survival.
Research Focus
Key Achievements
Top Papers
- 1
- 2